Related references
Note: Only part of the references are listed.IκB Kinase Inhibitor Attenuates Sepsis-Induced Cardiac Dysfunction in CKD
Jianmin Chen et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2017)
In vivo efficacy of the AKT inhibitor ARQ 092 in Noonan Syndrome with multiple lentigines-associated hypertrophic cardiomyopathy
Jianxun Wang et al.
PLOS ONE (2017)
Deletion of Interleukin-6 Attenuates Pressure Overload-Induced Left Ventricular Hypertrophy and Dysfunction
Lin Zhao et al.
CIRCULATION RESEARCH (2016)
Developmental SHP2 dysfunction underlies cardiac hypertrophy in Noonan syndrome with multiple lentigines
Jessica Lauriol et al.
JOURNAL OF CLINICAL INVESTIGATION (2016)
Hypoxia-stimulated cardiac fibroblast production of IL-6 promotes myocardial fibrosis via the TGF-β1 signaling pathway
Jia-Hong Wang et al.
LABORATORY INVESTIGATION (2016)
Low-dose dasatinib rescues cardiac function in Noonan syndrome
Jae-Sung Yi et al.
JCI INSIGHT (2016)
Rapidly Progressive Hypertrophic Cardiomyopathy in an Infant with Noonan Syndrome with Multiple Lentigines: Palliative Treatment with a Rapamycin Analog
Andreas Hahn et al.
AMERICAN JOURNAL OF MEDICAL GENETICS PART A (2015)
The varying faces of IL-6: From cardiac protection to cardiac failure
Jillian A. Fontes et al.
CYTOKINE (2015)
SHP2 sails from physiology to pathology
Mylene Tajan et al.
EUROPEAN JOURNAL OF MEDICAL GENETICS (2015)
Molecular Basis of Gain-of-Function LEOPARD Syndrome-Associated SHP2 Mutations
Zhi-Hong Yu et al.
BIOCHEMISTRY (2014)
Amplification of MPZL1/PZR promotes tumor cell migration through Src-mediated phosphorylation of cortactin in hepatocellular carcinoma
Deshui Jia et al.
CELL RESEARCH (2014)
PZR Coordinates Shp2 Noonan and LEOPARD Syndrome Signaling in Zebrafish and Mice
Jeroen Paardekooper Overman et al.
MOLECULAR AND CELLULAR BIOLOGY (2014)
Structural insights into Noonan/LEOPARD syndrome-related mutants of protein-tyrosine phosphatase SHP2 (PTPN11)
Wei Qiu et al.
BMC STRUCTURAL BIOLOGY (2014)
One-Step Generation of Mice Carrying Mutations in Multiple Genes by CRISPR/Cas-Mediated Genome Engineering
Haoyi Wang et al.
CELL (2013)
One-Step Generation of Mice Carrying Reporter and Conditional Alleles by CRISPR/Cas-Mediated Genome Engineering
Hui Yang et al.
CELL (2013)
Síndrome LEOPARD: una variante del síndrome de Noonan con fuerte asociación a miocardiopatía hipertrófica
Atilano Carcavilla et al.
REVISTA ESPANOLA DE CARDIOLOGIA (2013)
Inhibition of Signal Transducer and Activator of Transcription 3 (STAT3) Attenuates Interleukin-6 (IL-6)-induced Collagen Synthesis and Resultant Hypertrophy in Rat Heart
Saiful Anam Mir et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
Cardiomyocyte-specific IκB kinase (IKK)/NF-κB activation induces reversible inflammatory cardiomyopathy and heart failure
Harald J. Maier et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Rapamycin reverses hypertrophic cardiomyopathy in a mouse model of LEOPARD syndrome-associated PTPN11 mutation
Talita M. Marin et al.
JOURNAL OF CLINICAL INVESTIGATION (2011)
Hypertrophic cardiomyopathy: from genetics to treatment
Ali J. Marian
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION (2010)
Interleukin 6 Mediates Myocardial Fibrosis, Concentric Hypertrophy, and Diastolic Dysfunction in Rats
Giselle C. Melendez et al.
HYPERTENSION (2010)
Targeted Deletion of Nuclear Factor κB p50 Enhances Cardiac Remodeling and Dysfunction Following Myocardial Infarction
Leo Timmers et al.
CIRCULATION RESEARCH (2009)
A novel IKK inhibitor suppresses heart failure and chronic remodeling after myocardial ischemia via MMP alteration
Shin Wakatsuki et al.
EXPERT OPINION ON THERAPEUTIC TARGETS (2008)
Noonan syndrome-associated SHP-2/Ptpn11 mutants enhance SIRPα and PZR tyrosyl phosphorylation and promote adhesion-mediated ERK activation
Seda Eminaga et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
Blockade of NF-κB using IκBα dominant-negative mice ameliorates cardiac hypertrophy in myotrophin-overexpressed transgenic mice
David Young et al.
JOURNAL OF MOLECULAR BIOLOGY (2008)
Leopard syndrome
Anna Sarkozy et al.
ORPHANET JOURNAL OF RARE DISEASES (2008)
The murine ortholog of the SHP-2 binding molecule, PZR accelerates cell migration on fibronectin and is expressed in early embryo formation
Maria G. Roubelakis et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2007)
Protein tyrosine phosphatase function: the substrate perspective
Tony Tiganis et al.
BIOCHEMICAL JOURNAL (2007)
Blockade of NF-κB improves cardiac function and survival after myocardial infarction
Shunichi Kawano et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2006)
PTPN11 (Shp2) mutations in LEOPARD syndrome have dominant negative, not activating, effects
MI Kontaridis et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
An Shp2/SFK/Ras/Erk signaling pathway controls trophoblast stem cell survival
WT Yang et al.
DEVELOPMENTAL CELL (2006)
Diversity and functional consequences of germline and somatic PTPN11 mutations in human disease
M Tartaglia et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2006)
Cardioprotection afforded by NF-κB ablation is associated with activation of Akt in mice overexpressing TNF-α
Y Higuchi et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2006)
Role of interleukin-6 in cardiomyocyte/cardiac fibroblast interactions during myocyte hypertrophy and fibroblast proliferation
S Fredj et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2005)
Cardiac-specific blockade of NF-κB in cardiac pathophysiology:: differences between acute and chronic stimuli in vivo
M Brown et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2005)
Blockade of NF-κB improves cardiac function and survival without affecting inflammation in TNF-α-induced cardiomyopathy
N Kawamura et al.
CARDIOVASCULAR RESEARCH (2005)
Prognostic, therapeutic, and mechanistic implications of a mouse model of leukemia evoked by Shp2 (PTPN11) mutations
MG Mohi et al.
CANCER CELL (2005)
Influence of cytokines and growth factors in ANG II-mediated collagen upregulation by fibroblasts in rats: role of myocytes
S Sarkar et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2004)
Blocking the function of tyrosine phosphatase SHP-2 by targeting its Src homology 2 domains
RX Zhao et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Interleukin-6 family of cytokines mediates isoproterenol-induced delayed STAT3 activation in mouse heart
F Yin et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
c-Src-dependent tyrosine phosphorylation of IKKβ is involved in tumor necrosis factor-α-induced intercellular adhesion molecule-1 expression
WC Huang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Common pathways for primary hypertrophic and dilated cardiomyopathy
E Kroumpouzou et al.
HYBRIDOMA AND HYBRIDOMICS (2003)
Cardiac hypertrophy: The good, the bad and the ugly
N Frey et al.
ANNUAL REVIEW OF PHYSIOLOGY (2003)
Cell surface glycoprotein PZR is a major mediator of concanavalin A-induced cell signaling
RX Zhao et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Mutations in PTPN11, encoding the protein tyrosine phosphatase SHP-2, cause Noonan syndrome
M Tartaglia et al.
NATURE GENETICS (2001)
Cardiac-specific abrogation of NF-kappa B activation in mice by transdominant expression of a mutant I kappa B alpha
B Dawn et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2001)
Hypertrophic cardiomyopathy: the interrelation of disarray, fibrosis, and small vessel disease
AM Varnava et al.
HEART (2000)
Dissecting the interaction of SHP-2 with PZR, an immunoglobulin family protein containing immunoreceptor tyrosine-based inhibitory motifs
RX Zhao et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
Morphology and significance of the left ventricular collagen network in young patients with hypertrophic cardiomyopathy and sudden cardiac death
J Shirani et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2000)
Share Paper
